Lysergic Acid Diethylamide (LSD-25) and Ego Functions
The DOI matches its Crossref record.
Abstract
In 1947, Stoll32in Switzerland reported on the effects of D-lysergic acid diethylamide (LSD-25), an ergot derivative which can produce profound psychological effects in humans when it is given in minute doses. Since that time, a large volume of literature has grown up around this substance. LSD has been put to many uses. Its chemical interactions within the body have been studied with the as yet unrealized hope of finding a chemical basis for mental illness. It has been of considerable value in the basic study of the physiology of the central nervous system. It is hailed by some as a dramatically effective adjunct to treating mental illness and is employed in many uncontrolled studies for this purpose. Thus far its greatest value, in my opinion, has been as an experimental means of studying psychological functions. Study of the psychological changes associated with LSD administration has
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI).
Nour, M. M., Evans, L., Nutt, D., & Carhart-Harris, R. L. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00269 · Cited by 470
“Distortions in the subjective experience of one’s ‘‘self’’, or ‘‘ego’’, are central to the psychedelic experience (James, 1882; Huxley, 1954; Savage, 1955; Klee, 1963; Leary et al., 1964; Grof, 1976, 1980; Harrison, 2010; Carhart-Harris et al., 2014; Lebedev et al., 2015).”
BackgroundInfluentialStrassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453
Psychedelics, meditation, and self-consciousness
Millière, R., Carhart-Harris, R. L., Roseman, L., Trautwein, F.-M., & Berkovich-Ohana, A. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.01475 · Cited by 390
“…mescaline (Mayer-Gross and Stein, 1926; Beringer, 1927; Guttmann and Maclay, 1937), LSD (Anderson and Rawnsley, 1954; Savage, 1955; Von Mering et al., 1955; Bercel et al., 1956; Klee, 1963; Sedman and Kenna, 1964; Pahnke and Richards, 1966) and psilocybin (Rümmele and Gnirss, 1961; Pahnke, 1966).”
Enhanced repertoire of brain dynamical states during the psychedelic experience
Tagliazucchi, E., Carhart‐Harris, R., Leech, R., Nutt, D., & Chialvo, D. R. (2014) · Human Brain Mapping · doi:10.1002/hbm.22562 · Cited by 397
Self unbound: ego dissolution in psychedelic experience
Letheby, C., & Gerrans, P. (2017) · Neuroscience of Consciousness · doi:10.1093/nc/nix016 · Cited by 293
“Savage (1955) and Klee (1963) both suggest explanations of ego dissolution in terms of failures of mechanisms of cognitive integration, and view these compromised perceptual (particularly interoceptive) integrative mechanisms as the basis of the self-model: ‘Lacking a reliable inflow (or…”
Background
Metadata
- Authors
- KLEE, G. D.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1963-05-01
- Volume
- 8
- Issue
- 5
- Pages
- 461
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W1981113766
- Cited by
- 60
- References
- 0
- FWCI
- 6.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lysergic Acid Diethylamide (LSD-25) and Ego Functions. https://app.cochat.ai/papers/10.1001/archpsyc.1963.01720110037005
- The paper
- KLEE, G. D. (1963). Lysergic Acid Diethylamide (LSD-25) and Ego Functions. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1963.01720110037005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.